Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
about
Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
description
clinical trial
@en
klinisch onderzoek
@nl
name
Reduced-Intensity Busulfan and ...... ologic Cancer or Other Disease
@en
type
label
Reduced-Intensity Busulfan and ...... ologic Cancer or Other Disease
@en
prefLabel
Reduced-Intensity Busulfan and ...... ologic Cancer or Other Disease
@en
P1050
P4844
P1476
Allogeneic Hematopoietic Cell ...... Intensive Therapeutic Regimen
@en
P3098
NCT00448201
P580
2011-01-07T00:00:00Z
P582
2011-01-11T00:00:00Z